Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer

A Larcher, M Sun, P Dell'Oglio, V Trudeau, K Boehm, J Schiffmann, Z Tian, Nicola Fossati, U Capitanio, A Briganti, F Montorsi, Pierre I. Karakiewicz

Research output: Contribution to journalArticle

Abstract

Background: Local tumour ablation (LTA) may yield better perioperative outcomes than partial nephrectomy (PN), however the impact of each treatment on perioperative mortality and health care expenditures is unknown. The aim of the study was to compare mortality, morbidity and health care expenditures between LTA and PN. Patients and methods: A population-based assessment of 2471 patients with cT1a kidney cancer treated with either LTA or PN, between 2000 and 2009, in the SEER-Medicare database was performed. After propensity score matching, 30-day mortality, overall and specific complication rates, length of stay, readmission rates and health care expenditures according to LTA or PN were estimated. Multivariable logistic and linear models addressed the effect of each specific LTA approach on overall complication rates, length of stay, readmission rates and health care expenditures. Results: The 30-day mortality was
Original languageEnglish
Pages (from-to)815-822
Number of pages8
JournalEuropean Journal of Surgical Oncology
Volume43
Issue number4
DOIs
Publication statusPublished - 2017

Fingerprint Dive into the research topics of 'Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer'. Together they form a unique fingerprint.

  • Cite this